Emily Ostertag

Associate, Washington, DC

Biography

Overview

Emily is an associate in the Technology Transactions Practice, within the Firm's Global M&A Group and Global IP Group. Emily has experience with a variety of transactional matters involving the development, acquisition, transfer, and licensing of intellectual property and information technology. She has represented clients in a wide range of industries, including technology, media, entertainment, oil and gas, and life sciences, among others.

Bars and Courts
District of Columbia Bar
New York State Bar
Education
JD
University of Virginia School of Law
BA
Columbia University
Languages
English

Experience

Representation of HighCape Capital Acquisition Corp. (NASDAQ: CAPA), a SPAC sponsored by HighCape Capital LP, a healthcare growth equity fund, in its US$1.46 billion business combination with Quantum-Si Incorporated, a pioneer in next generation semiconductor chip-based proteomics.

Representation of Zimmer Biomet Holdings, Inc. (NYSE: and SIX: ZBH), a global medical technology leader, and ZimVie Inc. (NASDAQ: ZIMV) in the spinoff of ZimVie, Zimmer Biomet's former dental and spine businesses.